Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00393419 · ClinicalTrials.gov registry record · NA

Federal Study of Adherence to Medications in the Elderly (FAME)

A NA study of Hypertension and Medication Adherence, sponsored by Walter Reed Army Medical Center.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT00393419 is a NA study of Hypertension and Medication Adherence that has completed, run by Walter Reed Army Medical Center. The registered enrollment target is 200 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00393419, a NA study of Hypertension and Medication Adherence, has completed, sponsored by Walter Reed Army Medical Center.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effect of a comprehensive pharmacy care program on medication adherence and persistence, blood pressure, and LDL cholesterol.

Interventions

  • BEHAVIORAL Comprehensive pharmacy care program

Study Locations (1)

District of Columbia

  • Walter Reed Army Medical Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2004-06
Est. Completion 2006-08
Phase NA

Sponsor

Walter Reed Army Medical Center

24 total trials

What the Registry Record Tells You About NCT00393419

The ClinicalTrials.gov registry entry for NCT00393419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (94% lower). The listed sponsor is Walter Reed Army Medical Center, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive pharmacy care program is the first listed.

NCT00393419 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT00393419 about?

NCT00393419 is a clinical study titled "Federal Study of Adherence to Medications in the Elderly (FAME)". The purpose of this study is to determine the effect of a comprehensive pharmacy care program on medication adherence and persistence, blood pressure, and LDL cholesterol.

What is the current status of trial NCT00393419?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2004-06. Estimated completion is 2006-08.

What conditions does trial NCT00393419 study?

This clinical trial studies the following conditions: Hypertension, Medication Adherence, Hyperlipidemia.

What interventions are being tested in trial NCT00393419?

The interventions under investigation include: Comprehensive pharmacy care program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00393419?

This trial is sponsored by Walter Reed Army Medical Center, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00393419 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.